INTRODUCTION {#S1}
============

There is considerable concern internationally about rising levels of antimicrobial resistance.[@B1],[@B2] Antibiotic resistance has now become a serious problem in many countries, in part because no new classes of antibiotics have been developed for decades.[@B3] Resistance develops wherever antibiotics are used, whether this use is appropriate or inappropriate, but inappropriate use increases resistance without giving benefits to patients.[@B4] There is considerable data available showing inappropriate use in developed countries.[@B5],[@B6],[@B7],[@B8]

While studies show high levels of antibiotic use and resistance in some developing countries,[@B9],[@B10],[@B11],[@B12],[@B13] many developing countries lack data on either use or resistance. Carrying out research on drug utilisation in developing countries can sometimes be challenging. In Samoa, there is no published data available on antibiotic consumption or resistance, although it is thought that a strain of community-acquired MRSA originated from Samoa.[@B14] Excessive use of antibiotics, including use for inappropriate conditions, is acknowledged as a problem by health professionals in Samoa. Antibiotics are not legally available without prescription from pharmacies, although in practice they are available. While total consumption of antibiotics is likely to be the critical factor in selecting resistance, under-use through inadequate dosing, and poor adherence by patients may also be important.[@B2] There are anecdotal reports, and interview data (as yet unpublished) suggests that these are also considerable problems in Samoa.

Samoa (formerly known as Western Samoa) consists of two large and some small islands in the South Pacific. The population is about 177,000, and the only city, Apia, is home to about 35,000 people. The health system is largely publicly funded (75.9%), with some contribution from development aid (8.7%).[@B15] Many Samoans migrate to New Zealand, Australia and the USA, and there is substantial movement between these countries. In the latest New Zealand Census (2001) 115,000 Samoan people lived in New Zealand, of whom 58% were born in New Zealand.[@B16] In Australia more than 50,000 people report Samoan ancestry[@B17], and 133,000 people in the US reported Samoan as one of their ethnicities.[@B18] Thus, if levels of antibiotic resistance are high in Samoa, this may have significant implications for the spread of resistance in these other countries.

In Samoa medicines for the public health care system are imported by the Ministry of Health, and then distributed to hospitals and health centres. Private pharmacies import medicines from wholesalers and the private hospital imports some medicines for use by in- and out-patients.

General practitioners do not usually dispense medicines although they may keep small stocks for emergencies, and one GP outside of Apia dispenses. Antibiotics are dispensed to consumers by: the four privately-owned community pharmacies in Apia (there are no private pharmacies outside of Apia); hospital pharmacies (both in-patients and out-patients at one public and one private hospital in Apia, and one public in Tuasivi on the other large island); and by nurses (and occasionally doctors) in other health centres outside Apia and Tuasivi (9 in total). Samoa has a severe shortage of trained personnel, with only about 40 doctors (almost all in Apia or Tuasivi) and seven qualified pharmacists (all based in Apia).

The aim of this study was to gather basic data on levels of antibiotic use in Samoa.

METHODS {#S2}
=======

Methods used were interviews with healthcare providers and examination of invoices; retrospective record review in hospitals, pharmacies and health centres, and prospective observation in private pharmacies. Ethical approval for the study was given by the Samoa Health Research and Ethics committee.

Total consumption of antibiotics in Samoa was obtained through reviewing invoices, records of orders, and by interviews with healthcare providers (collectively referred to as "ordering data" below). In the public hospital in Apia (which purchases on behalf of all the public health services, and also the dispensing GP) all orders for 2004 were recorded. Invoices for four months were obtained from one private pharmacy (as the basis for estimating yearly use). For the other two private pharmacies who purchase medicines (the fourth is supplied by one of these) and the private hospital, the person responsible for ordering was asked to estimate use of each formulation of each antibiotic for 2004.

Retrospective record review was used to determine: the proportion of prescriptions which included antibiotics, the quantity of antibiotics dispensed per prescription, the number of prescriptions in a one month period, and the overall amount dispensed in a month. Records examined were paper records of prescriptions in pharmacies, and entries into logbooks in health centres (medicines are prescribed and dispensed by the same staff in these centres and paper prescriptions are not used). Data was collected from all outlets for antibiotics in Samoa apart from one private pharmacy, and some rural health centres which have visits from nurse or doctor once a week, and are otherwise staffed by an enrolled nurse who does not prescribe antibiotics.

We aimed to examine all records for the month of November 2004, in order to avoid the Christmas period, when Samoa has a large influx of visitors. There is very little seasonal variation in temperature or weather, so there is no reason to assume that November would be different from other months. However some pharmacies and health centres were not able to show us their records for that period, because these had been discarded or mislaid. In these cases we took whatever period was available after November. In the main hospital we took a simple random sample of prescriptions (every ninth prescription) in November, because the number of prescriptions was unmanageably large. HAN spent several hours helping with dispensing at several of the pharmacies before data collection began, in order to find out how the dispensing was carried out, since it did not always match the prescription (e.g. in the hospital a standard 100ml bottle was dispensed when any quantity of suspension was prescribed).

In the hospitals and private pharmacies paper prescriptions were examined and details of how these would have been dispensed recorded on standard forms. Where necessary we asked pharmacy staff for advice. In the hospitals and private pharmacies we can identify the proportion of prescription clients who received an antibiotic. In the health centres, dispensing is recorded in books, divided into sections for each type of medicine. We recorded all medicines dispensed in our study period, but the organization of these books meant that although we could identify the proportion of medicines which were antibiotics, we could not identify discrete individual patients, and therefore were unable to determine the proportion of clients who received antibiotics.

One health centre recorded all patients seen, symptoms, diagnosis and treatment. We collected data on a series of 120 consecutive patients to see what kind of symptoms are presented to rural health centres, and the diagnoses for which antibiotics were dispensed.

Prospective data collection was used to identify the number of patient encounters where antibiotics are dispensed, and the proportion of antibiotic sales which were non-prescription. This took place over one day in each of two private pharmacies.

RESULTS {#S3}
=======

Ordering data were obtained from all importers of antibiotics. [Table 1](#T1){ref-type="table"} shows total consumption for Samoa in 2004 in grams, Defined Daily Doses (DDDs), and DDDs per 1000 inhabitants per day. The percentage of each drug and formulation which was ordered for the public sector is also presented.

###### 

Total imported antibiotics, 2004 (oral formulations only)

  ------------------- -------------------------- ------------------ ----------- --------- ----------- -------------------
  ATC code            Drug                       Formulation        total g     DDDs      \% public   DDD/1000 inh-days
  J01CA04             Amoxicillin                tablets/capsules   784,593     784,593   95.6%       
                                                 Suspensions        90,800      90,800    82.6%       
                                                 TOTAL              875,393     875,393               13.55
  J01CA01             Ampicillin                 tablets/capsules   2,000       1,000     0.0%        0.02
  J01CR02             Augmentin (co-amoxyclav)   tablets/capsules   198,057     198,057   94.7%       
                                                 Suspensions        24,775      24,775    88.3%       
                                                 TOTAL              222,832     222,832               3.45
  J01FA10             Azithromycin               tablets/capsules   452         1,505     0.0%        0.02
  J01DC04             Cefaclor                   tablets/capsules   3,950       3,950     0.0%        
  J01DC04             Cefaclor                   Suspensions        8,340       8,340     89.9%       
                                                 TOTAL              12,290      12,290                0.19
  J01DB01             Cephalexin (Keflex)        tablets/capsules   26,250      13,125    95.2%       0.20
  J01BA01             Chloramphenicol            tablets/capsules   32,000      10,667    93.8%       
                                                 Suspensions        3,965       1,322     94.6%       
                                                 TOTAL              35,965      11,988                0.19
  J01MA02             Ciprofloxacin              tablets/capsules   190,475     190,475   98.4%       2.95
  J01FF01             Clindamycin                tablets/capsules   5           4         0.0%        0.00
  JO1CF02             Cloxacillin                tablets/capsules   262,000     131,000   95.4%       
                                                 Suspensions        64,000      32,000    97.7%       
                                                 TOTAL              326,000     163,000               2.52
                      Co-trimoxazole             tablets/capsules   406,217               94.5%       
                                                 Suspensions        27,514                87.2%       
                                                 TOTAL              433,731     180,721               2.80
  J01AA02             Doxycycline                tablets/capsules   4,660       46,600    0.0%        0.72
  J01FA01             Erythromycin               tablets/capsules   210,125     210,125   95.2%       
                                                 Suspensions        27,550      27,550    90.7%       
                                                 TOTAL              237,675     237,675               3.68
  J01CF05             Flucloxacillin             tablets/capsules   267,750     133,875   93.4%       
                                                 Suspensions        36,700      18,350    95.4%       
                                                 TOTAL              304,450     152,225               2.36
  J01XD01             Metronidazole              tablets/capsules   169,400     112,933   94.5%       1.75
  J01MA06             Norfloxacillin             tablets/capsules   260         325       0.0%        0.01
  J01CE02             Penicillin V               tablets/capsules   177,750     88,875    98.5%       
  J01CE02             Penicillin V               Suspensions        37,685      18,843    99.5%       
                                                 TOTAL              215,435     107,718               1.67
  J01AA07             Tetracycline               tablets/capsules   77,750      77,750    80.4%       1.20
  TOTAL ANTIBIOTICS                                                 4,190,680             37.27       
  ------------------- -------------------------- ------------------ ----------- --------- ----------- -------------------

Almost two-thirds of antibiotics consumed were penicillins (63% of DDDs/1000inh-days). Macrolides made up 9.9% of consumption, quinolones 7.9%, sulphanamides and trimethoprim 7.5%, tetracyclines 5.2%. Consumption of cephalosporins was low (1%), and other antibiotics made up 5.2% of consumption.

Other antibiotic formulations ordered in 2004 were 3748 bottles of eye-drops, 4025 bottles of eardrops and 38,400 tubes of creams. This is the equivalent of one bottle of eye-drops per 47 people, one bottle of ear-drops per 44 people, and one tube of antibiotic cream per 4.6 people.

[Table 2](#T2){ref-type="table"} shows data from retrospective record review in the two hospitals, three private pharmacies, and five health centres studied. The percentage of prescriptions containing an antibiotic was similar in hospitals and private pharmacies. Antibiotics were a larger proportion of all items dispensed in health centres, but there was considerable variation between the health centres (range: 28.4 -- 73.3).

###### 

Dispensing in one month

  ------------------------ ------------------------------------------------------------------- ------------------------------------------------------ ------------------------------- ----------------------------------------------------
  Healthcare facility      Number of prescriptions in one month [(a)](#t2fn1){ref-type="fn"}   Percentage of prescriptions containing an antibiotic   Number of medicines dispensed   Antibiotics as a proportion of medicines dispensed
  Main public hospital     5,247                                                               68.3                                                   11,709                          29.2
  Second public hospital   1,663                                                               58.0                                                   3,823                           34.7
  HOSPITALS                6,910                                                               65.8                                                   15,613                          34.6
  Private pharmacy 1       808                                                                 68.8                                                   1,637                           39.8
  Private pharmacy 2       82                                                                  80.5                                                   457                             50.7
  Private pharmacy 3       654                                                                 68.2                                                   1,440                           38.8
  PHARMACIES               1,544                                                               69.2                                                   3,534                           36.4
  Health centre1           Data unavailable                                                                                                           308                             45.8
  Health centre 2          Data unavailable                                                                                                           191                             73.3
  Health centre 3          Data unavailable                                                                                                           457                             52.5
  Health centre 4          Data unavailable                                                                                                           296                             28.4
  Health centre 5          Data unavailable                                                                                                           601                             35.1
  HEALTH CENTRES           Data unavailable                                                                                                           1,853                           44.0
  TOTAL                                                                                        66.4                                                                                   34.68
  ------------------------ ------------------------------------------------------------------- ------------------------------------------------------ ------------------------------- ----------------------------------------------------

(a)corrected for differences in sampling

Eighty percent of prescriptions examined were for oral dosage forms (tablet, capsules or suspensions). The most commonly dispensed antibiotics were amoxycillin (29.6%) flucloxacillin (15.4%), co-trimoxazole (12.0%), cloxacillin (9.7%), erythromycin (8.3%), augmentin (7.1%), and penicillin V (6.4%). The average length of supply was 6.88 days.

Prospective observation showed that non prescription sale of antibiotics accounted for 24.7% (20/81) of total antibiotic sales on the days studied. The two pharmacies observed sold a similar proportion of antibiotics without prescription (23.8% in one pharmacy, and 25.6% in the other). The average intended length of supply for the over the counter antibiotics was 5.0 days. Flucloxacillin 500mg and tetracycline 250mg were the most common antibiotics purchased over the counter.

Of the 122 patients recorded in the health centre book, 30 (24.6%) were recorded as receiving an antibiotic. Diagnoses were recorded for 29 of these. Seven patients were given antibiotics for wounds, six for upper respiratory tract infections, five for abscesses, two for pneumonia, two for gastritis, one for rheumatic fever, one for otitis media, one for bronchiolitis, one for cellulitis, one for conjunctivitis, one chronic obstructive respiratory disease, and one dermatitis.

DISCUSSION {#S4}
==========

Data on overall consumption of medicines in DDDs are seldom available from developing countries, because this usually requires a high level of computerization. In developed countries such data are usually obtained from wholesalers or reimbursement systems. Because Samoa is so small it is possible to gather data on overall consumption by requesting it from all those who import medicines, and using paper records. This study found an overall use of antibiotics of 37.3 DDDs per 1000 inhabitant-days in Samoa. This is higher than that reported in any European country. Goossens et al report that in 26 European countries outpatient antibiotic consumption varied from 10.0 DDD per 1000 inhabitant-days in the Netherlands to 32.2 in France.[@B19] They report that outpatient data represents 90 to 94% of all use, and in fact their data includes hospital use in some countries.

Data on antibiotic consumption in developing countries is usually expressed using the WHO/INRUD indicator, percentage of encounters with an antibiotic prescribed.[@B20] In practice researchers often look at the percentage of prescriptions which include an antibiotic. Between 1988 and 2002, published and unpublished studies found that on average 40 to 60% of patients in health facilities in developing countries were prescribed antibiotics.[@B21] Antibiotic use in Samoa also appears to be high by this standard. In public hospitals and private pharmacies, 66.4% of prescriptions included an antibiotic. It seems likely that this figure is even higher in health centres, because antibiotics form a higher proportion of medicines dispensed there. Considerable variation was found between the five health centres studied, and this suggests that prescribers may vary substantially in their prescribing habits.

Both the aggregate consumption data and the prescription analysis suggest a high level of use of penicillins compared to that found in other developing countries. For example in Kenya, penicillins made up only 31% of antibiotic consumption,[@B22] and in a Sri Lankan study 37.7% of all prescriptions, and 42.9% of prescriptions for children were for penicillin.[@B23],[@B24] In a Malaysian study erythromycin was the most commonly prescribed antibiotic in primary care,[@B25] while in Samoa it accounted for only 10% of use expressed in DDDs.

By law, antibiotics are not available over the counter in pharmacies in Samoa. However, in practice, many antibiotics are purchased in this way. This is common in many developing countries. In Samoa, pharmacy staff report selling antibiotics over the counter for a range of reasons, such as patient inability to afford to see a doctor, long waiting times at the hospital, and concern that untreated infections may become serious. Much of the over the counter sale is reported to be for self-treatment for boils. There is little evidence of very short courses of antibiotics being dispensed, as has been reported in other developing countries.[@B26],[@B27] The prevalence of over the counter sales of antibiotics means that studies based on prescriptions are likely to significantly under-estimate the volume of antibiotics sold in pharmacies.

Drug utilization research in developing countries presents some difficulties, and therefore the study methodology varied from the ideal. The destruction or loss of paper records meant that the sampling timeframe varied somewhat in different facilities. Ideally the period of prospective observation in pharmacies would have been longer. Our method of obtaining ordering data relied in two cases on pharmacist or doctor recall of orders (with prompting). However together these form a small proportion of the total consumption. The most significant orderer was the public hospital in Apia and paper records were used there. The final result may still be a slight-underestimate because some supplementary orders by the hospital may not have been recorded. On the other hand volumes in private pharmacies may be slight over-estimates because sometimes people purchase quite large quantities of antibiotics in Samoa to take to New Zealand, where they are not available without a prescription, and are more expensive. The study has shown that in very small developing countries it is possible to calculate total consumption of medicines in DDDs.

The high level of use of antibiotics in Samoa is concerning. Further research is need on resistance levels, and appropriate strategies to reduce antibiotic use should be implemented.
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